U.S. FDA proposes new method for breast cancer drug trials
BETHESDA, MD _ The Food and Drug Administration has drafted a regulatory guidance describing a new way of conducting breast cancer drug trials that promises to reduce substantially the time and cost of getting new treatments to patients.